A day after Modi said his government may bring in such a law to benefit patients, Kumar said the parliamentary committee headed by him had made such a recommendation in 2012 as generic drugs cost less than half of branded medicines and are equally effective.
Kumar said the move will provide the poor cheap drugs without any government expenditure.
The veteran parliamentarian, who is a Lok Sabha member from Kangra, said in a statement that patients in India are denied generic drugs as doctors "benefit" from pharmaceutical companies for writing branded medicines.
Kumar (82), said he met and often wrote to the then prime minister, health minister and chemical and fertiliser minister for accepting its recommendations but in vain.
"By making this announcement, Modi has proved that his government is dedicated to the poor. The Congress government could not take such a decision because it worked under the pressure of multi-national pharma companies while the Modi government works under the pressure of helping the poor," he said.
Calling the recommendation of the committee path- breaking, he said he was grateful to 30 other MPs, who were its members and belonged to different parties.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
